According to the latest Business Monitor International (BMI) report on Pharmaceuticals and Healthcare in Lebanon, the market will register modest growth in the next few years. BMI believes that, among other elements, “the public’s preference for branded medicines as well as an increasing chronic disease burden will ensure the demand for patented medicine will continue”. Market growth will however be restrained by Lebanon’s small population, strict medicine pricing regulations and high political risks. The latter recently materialized by the recent resignation of Prime Minister Saad Hariri which placed the country in a familiar scenario of political paralysis.
BMI Pharmaceuticals and Healthcare Report 2017